Hebrew University of Jerusalem - Pharmaceuticals & Healthcare - Deals and Alliances Profile
September 2018
49
About the Report
About the Report
Summary
Hebrew University of Jerusalem (Hebrew University) is an educational service provider that offers graduation and training services. The university offers educational services in the areas of humanities, natural sciences, law, business administration, medicine, dental medicine, social science, agriculture, social work, brain sciences and others. It also offers international programs, cornerstone programs, English courses, Hebrew courses and pre academic studies. Hebrew University undertakes research in the field of agricultural economic research, nutrigenomics and functional food, plant sciences in agriculture, and others. The university operates various research centers across Israel. Hebrew University is headquartered in Jerusalem, Israel.
Hebrew University of Jerusalem-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Hebrew University of Jerusalem, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Hebrew University of Jerusalem, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Hebrew University of Jerusalem, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Hebrew University of Jerusalem, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Hebrew University of Jerusalem, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Hebrew University of Jerusalem, Medical Devices Deals, 2012 to YTD 2018 11
Hebrew University of Jerusalem, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Hebrew University of Jerusalem, Pharmaceuticals & Healthcare, Deal Details 15
Venture Financing 15
Atox Bio Raises USD30 Million in Financing 15
Avraham Pharma Raises up to USD4.5 Million Financing 17
Avraham Pharma Raises USD4.5 Million in Venture Financing 19
Avraham Pharma Raises USD 6 Million In Venture Financing 21
Integra Holdings Raises USD 7 Million In First Round Financing 23
Partnerships 24
Phytecs Enters into Agreement with Yissum Research Development 24
Kamada Enters into Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 25
Accurexa Enters into Agreement with Yissum Research Development 26
Yissum Research Development Expands Licensing Agreement with Israel Chemicals 27
Immune Pharma Plans to Partner with Hebrew University of Jerusalem 28
Hervana Enters into Research Partnership with Hebrew University 29
Licensing Agreements 30
BioLineRx Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 30
Spherium Biomed Enters into Option Agreement with Yissum 31
Therapix Biosciences to Enter into Licensing Agreement with Yissum Research Development Company 32
BioTheryX Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 33
Immune Pharma Enters into Licensing Agreement with Yissum 34
Immune Pharma to Enter into Licensing Agreement with Yissum Research Development 36
Yissum Research Development, Hadasit and Kennedy Trust Enter into Licensing Agreement with ISA Scientific 37
Yissum Research Development Enters into Licensing Agreement with PhytoTech Medical 38
Hebrew University Amends Licensing Agreement with TyrNovo 39
BioLineRx Enters Into Licensing Agreement With Yissum, B.G. Negev Technologies And Hadasit Medical 40
Acquisition 42
Guangxi Wuzhou Zhongheng Invests USD3 Million in Integra 42
Hebrew University of Jerusalem-Key Competitors 43
Hebrew University of Jerusalem-Key Employees 44
Hebrew University of Jerusalem-Locations And Subsidiaries 45
Head Office 45
Other Locations & Subsidiaries 45
Recent Developments 46
Government and Public Interest 46
Mar 26, 2017: New study shows circular RNA can encode for proteins 46
Other Significant Developments 48
Apr 24, 2018: Human gene atlas opens avenues for cancer and genetics studies 48
Appendix 49
Methodology 49
About GlobalData 49
Contact Us 49
Disclaimer 49
List of Figure
List of Figures
Hebrew University of Jerusalem, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Hebrew University of Jerusalem, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Hebrew University of Jerusalem, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Hebrew University of Jerusalem, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Hebrew University of Jerusalem, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Hebrew University of Jerusalem, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Hebrew University of Jerusalem, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Hebrew University of Jerusalem, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Hebrew University of Jerusalem, Medical Devices Deals, 2012 to YTD 2018 11
List of Table
List of Tables
Hebrew University of Jerusalem, Pharmaceuticals & Healthcare, Key Facts 2
Hebrew University of Jerusalem, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Hebrew University of Jerusalem, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Hebrew University of Jerusalem, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Hebrew University of Jerusalem, Deals By Therapy Area, 2012 to YTD 2018 9
Hebrew University of Jerusalem, Medical Devices Deals, 2012 to YTD 2018 11
Hebrew University of Jerusalem, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 12
Atox Bio Raises USD30 Million in Financing 15
Avraham Pharma Raises up to USD4.5 Million Financing 17
Avraham Pharma Raises USD4.5 Million in Venture Financing 19
Avraham Pharma Raises USD 6 Million In Venture Financing 21
Integra Holdings Raises USD 7 Million In First Round Financing 23
Phytecs Enters into Agreement with Yissum Research Development 24
Kamada Enters into Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 25
Accurexa Enters into Agreement with Yissum Research Development 26
Yissum Research Development Expands Licensing Agreement with Israel Chemicals 27
Immune Pharma Plans to Partner with Hebrew University of Jerusalem 28
Hervana Enters into Research Partnership with Hebrew University 29
BioLineRx Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 30
Spherium Biomed Enters into Option Agreement with Yissum 31
Therapix Biosciences to Enter into Licensing Agreement with Yissum Research Development Company 32
BioTheryX Enters into Licensing Agreement with Yissum Research Development Company of the Hebrew University of Jerusalem 33
Immune Pharma Enters into Licensing Agreement with Yissum 34
Immune Pharma to Enter into Licensing Agreement with Yissum Research Development 36
Yissum Research Development, Hadasit and Kennedy Trust Enter into Licensing Agreement with ISA Scientific 37
Yissum Research Development Enters into Licensing Agreement with PhytoTech Medical 38
Hebrew University Amends Licensing Agreement with TyrNovo 39
BioLineRx Enters Into Licensing Agreement With Yissum, B.G. Negev Technologies And Hadasit Medical 40
Guangxi Wuzhou Zhongheng Invests USD3 Million in Integra 42
Hebrew University of Jerusalem, Key Competitors 43
Hebrew University of Jerusalem, Key Employees 44
Hebrew University of Jerusalem, Subsidiaries 45
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.